Molbio Diagnostics Limited Stock Price Today (NSE: MOLBIO)

Molbio Diagnostics Limited

1263.80+45.00 (+3.69%)
Market Closed

Fundamental Score

...

Molbio Diagnostics Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Molbio Diagnostics Limited share price today is 1263.80, up +3.69% on NSE/BSE as of 22 September 2026. Molbio Diagnostics Limited (MOLBIO) is a Mid-cap company in the Unknown Industry sector with a market capitalisation of 14.25K (Cr). The 52-week high for MOLBIO share price is 1686.80 and the 52-week low is 926.35.

Molbio Diagnostics Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
1264.60
Low
926.35
Volume
32.5L
Change
+7.28%

Molbio Diagnostics Limited share price chart: 7.28% return over the past month. 52-week high ₹1686.80, 52-week low ₹926.35.

Molbio Diagnostics Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
1297.101314.801262.201288.3014.35L (Cr)
1313.501382.001272.101285.3038.01L (Cr)
1385.001437.601196.201307.0080.96L (Cr)
1419.701419.701273.001356.8037.74L (Cr)
1545.001686.801391.701438.20220.58L (Cr)
1271.001509.401271.001509.40113.30L (Cr)
1119.001293.501111.501257.9094.14L (Cr)
1127.201155.001110.201117.503.22L (Cr)
1170.001183.701098.201127.2010.68L (Cr)
1139.901177.001117.201160.505.94L (Cr)

Molbio Diagnostics Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
1072.301686.801035.201288.30+20.14%
980.001264.60926.351086.30+10.85%

Returns & Performance

Return on Equity (ROE)

N/A

Profit generated per ₹1 of shareholder equity

Return on Capital (ROCE)

N/A

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

N/A

Annual dividend as % of current share price

Molbio Diagnostics Limited Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Industry Avg P/E

N/A

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Promoter Holding

N/A

% shares held by company founders/management

FII Holding

N/A

% shares held by foreign institutional investors

DII Holding

N/A

% held by domestic mutual funds, LIC, banks

Promoter Pledged %

N/A

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Profit Growth (Quarterly YoY)

N/A

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Debt to Equity Ratio

N/A

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Molbio Diagnostics Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MOLBIO across key market metrics for learning purposes.

Positive Indicators

0 factors identified

No significant strengths identified in current analysis.

Risk Factors

0 factors identified

No significant concerns identified in current analysis.

Molbio Diagnostics Limited vs Sector Peers

Molbio Diagnostics Limited Quarterly Performance

Latest quarterly metrics for MOLBIO — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

N/A

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Molbio Diagnostics Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MOLBIO — calculated from daily price history

58RSI 14
Neutral — RSI 58

Momentum is balanced — neither overbought nor oversold.

30-Day Avg Volume
3250K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Molbio Diagnostics Limited Financial Statements

Annual income statement, balance sheet and cash flow for Molbio Diagnostics Limited (MOLBIO) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Molbio Diagnostics Limited

Loading latest quarterly results...

About MOLBIO (Molbio Diagnostics Limited)

Molbio Diagnostics Limited (MOLBIO) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Unknown Industry sector wit...h a current market capitalisation of ₹14.25K (Cr). Investors tracking MOLBIO share price can monitor key metrics including P/E ratio, promoter holding of N/A%, and quarterly earnings growth.

Company Details

Symbol:MOLBIO
Industry:N/A
Sector:N/A
Website:N/A

MOLBIO Share Price: Frequently Asked Questions

What is the current share price of Molbio Diagnostics Limited?

Molbio Diagnostics Limited (MOLBIO) trades at ₹1263.80 on NSE. Market cap ₹14.25K (Cr). Educational data only.

What is the P/E ratio of Molbio Diagnostics Limited?

Molbio Diagnostics Limited has a P/E of N/Ax vs industry average N/Ax.

What is the Bull Run score for Molbio Diagnostics Limited?

Molbio Diagnostics Limited has a Bull Run score of 0/100 based on 25+ financial parameters.

Does Molbio Diagnostics Limited pay dividends?

Molbio Diagnostics Limited has a dividend yield of N/A. Past dividends don't guarantee future payments.

What is the ROE of Molbio Diagnostics Limited?

Molbio Diagnostics Limited has ROE of N/A. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Molbio Diagnostics Limited?

Molbio Diagnostics Limited has debt-to-equity of N/A.

Is Molbio Diagnostics Limited a good investment?

Bull Run gives Molbio Diagnostics Limited a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.